Cargando…
Platelet-derived growth-factor requirements for in vitro proliferation of normal and malignant mesenchymal cells.
Serum obtained by clotting whole blood contains a potent mitogen with apparent specificity for mesenchymal cells. This peptide wound-healing hormone, derived from platelets, is known as platelet-derived growth factor (PDGF). Serum obtained by clotting plasma contains no detectable growth-promoting a...
Autor principal: | Currie, G. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1981
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010611/ https://www.ncbi.nlm.nih.gov/pubmed/7225284 |
Ejemplares similares
-
Platelet-derived growth factor signaling in human malignancies
por: Liu, Kun-Wei, et al.
Publicado: (2011) -
Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors
por: Ball, Stephen G, et al.
Publicado: (2007) -
Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling
por: Pinto, Mauricio P, et al.
Publicado: (2014) -
Platelet-rich plasma affects the proliferation of canine bone marrow-derived mesenchymal stromal cells in vitro
por: Pandey, Sony, et al.
Publicado: (2019) -
miR-15b induced by platelet-derived growth factor signaling is required for vascular smooth muscle cell proliferation
por: Kim, Sunghwan, et al.
Publicado: (2013)